Thank you!

Your quote has been successfully submitted!

For products requiring additional information, our team will contact you within 1 business day

Failed

There was an error submitting your quote. Please try again.

Recombinant Human Vaspin/SerpinA12 Protein (GST Tag)– MSE Supplies LLC

Free Shipping on MSE PRO Online Orders of $500 or More! U.S. Orders Only * Offer Excludes Hazmat Shipments *

Menu

This product has been added to the cart.

Recombinant Human Vaspin/SerpinA12 Protein (GST Tag)

SKU: PKSH033534-50

  • £39400
  • Save £4400



Recombinant Human Vaspin/SerpinA12 Protein (GST Tag)

 

SKU # PKSH033534
Expression Host E.coli

 

 

Description

Synonyms OL-64, SERPINA12, Serpin A12, Vaspin, Visceral Adipose Tissue-Derived Serine Protease Inhibitor, Visceral Adipose-Specific Serpin
Species Human
Expression Host E.coli
Sequence Leu21-Lys414
Accession Q8IW75
Calculated Molecular Weight 71.4 kDa
Observed Molecular Weight 72 kDa
Tag N-GST
Bio-activity Not validated for activity
  

 

Properties

Purity > 80 % as determined by reducing SDS-PAGE.
Endotoxin < 1.0 EU per μg of the protein as determined by the LAL method.
Storage Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.
Shipping This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at < - 20°C.
Formulation Supplied as a 0.2 μm filtered solution of 50mM Tris-HCl, 160mM NaCl, 0.2mM PMSF, 1mM DTT, 10% Glycerine, pH 7.2 .
Reconstitution Not Applicable



Background

Vaspin (Visceral Adipose-Specific SERPIN) is a newly described adipokine. Vaspin has three β-sheets; nine α-helices; and one central loop; the structure is part of the set of distinctive features that are descriptive of Serpin family members. Vaspin is also a unique insulin sensitizing adipocytokine in obesity. A recent publication indicates that Vaspin mRNA expression in visceral fat is positively correlated with BMI and percent of body fat. and could be associated with parameters of obesity; insulin resistance; and glucose metabolism. These findings suggest a potential clinical use for Vaspin in ameliorating certain aberrations seen in the obesity metabolic syndrome.